Florida Cancer Specialists & Research Institute, LLC (FCS) advances genitourinary cancer treatment through participation at the global ASCO® 2026 Genitourinary (GU) Cancers Symposium meeting this ...

Of the phase III trials that planned to report QoL outcomes, nearly 40% never did ...

(UroToday.com) The 2026 GU ASCO annual meeting featured a kidney cancer trials in progress session and a presentation by Dr. Laurence Albiges discussing REJOICE-PanTumor01, a phase 2 signal-seeking ...

The presentations at ASCO GU signal a move toward more personalized, potent, and sequence-specific treatment strategies for genitourinary malignancies.

When a doctor suspects bladder cancer, they will order a series of tests which may include urine tests (urinalysis or urine ...

HealthDay News — Microplastics have been found in most prostate tumors, according to a small study presented at the American Society of Clinical Oncology annual Genitourinary Cancers Symposium, held ...

An evaluation of 10 men with prostate cancer found 90% had microplastics in their tumors, with concentrations more than double that found in surrounding benign prostate tissue.The data, which will be ...

A new study has uncovered a troubling potential link between microplastics and cancerous prostate tumors. While the study doesn't prove causation, it raises questions about the effects microplastics ...

A systematic literature review was performed on March 2023 using PubMed, MEDLINE, and Embase databases according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement.

A study presented at the American Society of Clinical Oncology’s Genitourinary Cancers Symposium last week had some scary takeaways.  The author | Cancer ...